OTC labeling
This article was originally published in The Tan Sheet
Executive Summary
Generic labeling mock-ups for cimetidine 200 mg tablets, loperamide HCl (1 mg oral solution and 2 mg chewable tablets) and acetaminophen suppositories (120 mg, 325 mg and 650 mg) posted on FDA's OTC Web site (www.fda.gov/cder/otc). Reference labels are second wave published by agency to enable private labelers to implement OTC labeling final rule before reference listed drug holders change their labeling. First set of mock-ups was released in February; naproxen sodium tablets and miconazole vaginal cream labeling expected soon (1"The Tan Sheet" Feb. 26, p. 4)
You may also be interested in...
Generic Drug Revised Labeling Mock-Ups Available On FDA Web Site
Private label firms will be able to reference labeling examples for seven OTC drug categories when revising product labeling to conform to the provisions of the OTC labeling final reg, FDA asserts in a draft guidance for industry published in the Feb. 22 Federal Register.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands